Search
forResearch 10 of 37
- Skin Impacts and Tradeoffs of GLP-1 Therapy: Improved Patient-Reported Outcomes of Inflammatory Skin Disease in the Era of “Ozempic Face”
- GLP-1 e Estética: Ozempic Face, Flacidez e Recuperação
- GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
- Semaglutide Treatment of Excessive Body Weight in Obese PCOS Patients Unresponsive to Lifestyle Programs
- Risk of Suicide, Hair Loss, and Aspiration with GLP1-Receptor Agonists and Other Diabetic Agents: A Real-World Pharmacovigilance Study
- Alopecia and Semaglutide: Connecting the Dots for Patient Safety
- Targeting Obesity in PCOS: A Review of Current Pharmacological Interventions and Future Directions
- Nonscarring Alopecia in Adults Treated With GLP ‐1s: A Propensity Score Matched TriNetX Cohort Study
- EFLÚVIO TELÓGENO ASSOCIADO AO USO DE MEDICAMENTOS EMAGRECEDORES: MECANISMOS FISIOPATOLÓGICOS E EVIDÊNCIAS CLÍNICAS
- 0439 Temporal–phenotype signatures of alopecia associated with GLP-1–based therapies: A PRISMA-ScR scoping review
Community 3 of 4
- Will Pp405 be the Ozempic of bald Guys
- Wouldn’t it be funny if there already was a drug that existed which reactivated sleeping follicles? It would be our own version of Ozempic
- Finally - Big Pharma now targeting hair-loss once again!
Learn
— no results
Try a deeper search in learn →